According to this new report, the global phacoemulsification market is estimated to be valued at US$ 385 million in the year 2028, growing at a CAGR of 4.5% in the period 2020 to 2028. Growth of the market is driven by the prevalence of cataract cases, the rise in the number of diabetics, the increasing geriatric population and the minimally invasive nature of the procedure.
Phacoemulsification is a modern cataract surgery which deals with emulsification or liquefaction of the natural lens of the eye. It uses an ultrasonic probe to break up and remove a cloudy lens, or cataract from the eyes. The technique has become a gold standard for cataract surgery globally due to its relatively higher visual rehabilitation outcome.
Technological prowess in the ophthalmology industry has led to the development of new advanced phacoemulsification systems with exceptional versatility. These systems portray simplified graphical UI, wireless remote control and various other advanced features.
Segments Covered
The report provides revenue forecasts for global, regional and country levels. It also provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. For the purpose of research, the publisher has segmented the global phacoemulsification market report on the basis of geography and product types.
Product Type Outlook
Regional Outlook
Vendors Outlook
Target Audience
